Abstract
As malaria continues to be a worldwide problem due to increasing drug resistance, several drug susceptibility techniques have been reported in the literature. A particularly confounding problem is the lack of standardization between methods that result in differences in sensitivities. In this review, we report on the types of antimalarial drug susceptibility assays available to clinical and research investigators. Techniques based on enzyme-linked immunosorbent assays (ELISAs), fluorescence, molecular assays, and optical methods will be outlined. Strengths and weaknesses, as well as field applicability, will be discussed. Furthermore, assay and culture conditions, particularly for the fluorescence-based assays, will also be detailed.
Keywords: Antimalarials, drug susceptibility, ELISA, fluorescence, molecular assays, real-time polymerase chain reaction, optical imaging, Plasmodium
Anti-Infective Agents in Medicinal Chemistry
Title: Recent Methods in Antimalarial Susceptibility Testing
Volume: 9 Issue: 3
Author(s): E.M.A. Co, S.M. Johnson, T. Murthy, M. Talwar, M.R. Hickman and J.D. Johnson
Affiliation:
Keywords: Antimalarials, drug susceptibility, ELISA, fluorescence, molecular assays, real-time polymerase chain reaction, optical imaging, Plasmodium
Abstract: As malaria continues to be a worldwide problem due to increasing drug resistance, several drug susceptibility techniques have been reported in the literature. A particularly confounding problem is the lack of standardization between methods that result in differences in sensitivities. In this review, we report on the types of antimalarial drug susceptibility assays available to clinical and research investigators. Techniques based on enzyme-linked immunosorbent assays (ELISAs), fluorescence, molecular assays, and optical methods will be outlined. Strengths and weaknesses, as well as field applicability, will be discussed. Furthermore, assay and culture conditions, particularly for the fluorescence-based assays, will also be detailed.
Export Options
About this article
Cite this article as:
Co E.M.A., Johnson S.M., Murthy T., Talwar M., Hickman M.R. and Johnson J.D., Recent Methods in Antimalarial Susceptibility Testing, Anti-Infective Agents in Medicinal Chemistry 2010; 9 (3) . https://dx.doi.org/10.2174/1871521411009030148
DOI https://dx.doi.org/10.2174/1871521411009030148 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Understanding The Role of Inflammasome in Angina Pectoris
Current Protein & Peptide Science Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies
Current Pharmacogenomics and Personalized Medicine The Role of Mitogen-Activated Protein Kinases in Asthma
Current Immunology Reviews (Discontinued) A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Phosphatidylserine and Curcumin Act Synergistically to Down-Regulate Release of Interleukin-1β from Lipopolysaccharide-Stimulated Cortical Primary Microglial Cells
CNS & Neurological Disorders - Drug Targets Intramolecular Haloetherification and Transannular Hydroxycyclization of Alkenes. A Synthetic Methodology to Obtain Polycyclic Ethers and Amines
Current Organic Chemistry Pomolic Acid Isolated from the Leaves of Licania pittieri Inhibits ADP-and Epinephrine-Induced Platelet Aggregation and has Hypotensive Effect on Rats
Current Bioactive Compounds ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries
Current Drug Targets Molecular Docking Study for Analyzing the Inhibitory Effect of Anti-inflammatory Plant Compound Against Tumour Necrosis Factor (TNF-α)
Current Drug Therapy Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Current Cancer Drug Targets Mesenchymal Stromal Cells: A Promising Cell Source for the Treatment of Inflammatory Cardiomyopathy
Current Pharmaceutical Design Editorial (Cellular Senescence and Inflammation: Advances and Therapeutic Targets in Aging and Major Age-Related Diseases)
Current Pharmaceutical Design Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
Current Medicinal Chemistry Chemical Analysis of the Chinese Herbal Medicine Turmeric (Curcuma longa L.)
Current Pharmaceutical Analysis Cornea and Ocular Surface Treatment
Current Stem Cell Research & Therapy Cyanopeptides: A New and Nearly Inexhaustible Natural Resource for the Design and Structure-Activity Relationship Studies of New Inhibitors of Trypsin-like Serine Proteases
Current Enzyme Inhibition The Discovery and Application of Inhibitors of Glutathione S-Transferase as Therapeutic Agents -A Review
Current Bioactive Compounds Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology Immune System Alterations by Aldosterone During Hypertension: From Clinical Observations to Genomic and Non-Genomic Mechanisms Leading to Vascular Damage
Current Molecular Medicine